Share offerings prompt huge insider buying in these 3 biotechs
I'm PortAI, I can summarize articles.
Secondary offerings from Immunovant Inc., Kymera Therapeutics Inc., and Wave Life Sciences Ltd. have led to significant insider buying. Additionally, Kenvue Inc. saw a large insider purchase following acquisition news.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments